|By Marketwired .||
|March 18, 2014 12:17 PM EDT||
NEW YORK, NY -- (Marketwired) -- 03/18/14 -- The Rosen Law Firm, P.A. today reminds all purchasers of the common stock of Galena Biopharma, Inc. (NASDAQ: GALE) between November 6, 2013 and February 14, 2014, inclusive of the important May 5, 2014 lead plaintiff deadline.
To join the Galena class action, go to the website at http://rosenlegal.com or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that Galena was engaged in misleading stock promotion. When this adverse information entered the market, the price of Galena stock fell, damaging investors. As a result, the SEC is now investigating Galena.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 5, 2014. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe concentrating its practice in securities class actions.